NCT04758949: A trial that was reported late by Flame Biosciences
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT04758949 |
|---|---|
| Title | A Two-cohort, Phase 2 Study of FL-101 as Neoadjuvant Therapy in Patients With Surgically Resectable Non-Small Cell Lung Cancer |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Aug. 25, 2021 |
| Completion date | Oct. 30, 2022 |
| Required reporting date | Oct. 30, 2023, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Jan. 12, 2022 |
| Days late | None |